Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fluorides and osteoporosis.

M Kleerekoper1, R Balena

  • 1Bone and Mineral Division, Henry Ford Hospital, Detroit, Michigan 48202.

Annual Review of Nutrition
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Sodium fluoride significantly impacts bone health, offering both benefits and toxicity. Further research into its mechanisms is crucial to optimize its use for brittle bone diseases like osteoporosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A direct comparison of long- and short-acting GLP-1 receptor agonists (taspoglutide once weekly and exenatide twice daily) on postprandial metabolism after 24 weeks of treatment.

Diabetes, obesity & metabolism·2013
Same author

Combination therapy with GLP-1 receptor agonists and basal insulin: a systematic review of the literature.

Diabetes, obesity & metabolism·2012
Same author

Efficacy and tolerability of taspoglutide versus pioglitazone in subjects with type 2 diabetes uncontrolled with sulphonylurea or sulphonylurea-metformin therapy: a randomized, double-blind study (T-emerge 6).

Diabetes, obesity & metabolism·2012
Same author

Taspoglutide, a once-weekly glucagon-like peptide 1 analogue, vs. insulin glargine titrated to target in patients with Type 2 diabetes: an open-label randomized trial.

Diabetic medicine : a journal of the British Diabetic Association·2012
Same author

Safety and tolerability of high doses of taspoglutide, a once-weekly human GLP-1 analogue, in diabetic patients treated with metformin: a randomized double-blind placebo-controlled study.

Diabetic medicine : a journal of the British Diabetic Association·2010
Same author

Pharmacokinetic and pharmacodynamic properties of taspoglutide, a once-weekly, human GLP-1 analogue, after single-dose administration in patients with Type 2 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2009
Same journal

Mechanisms of NAD+ Homeostasis in Aging and Disease.

Annual review of nutrition·2026
Same journal

Metabolite Damage and Repair in Health and Disease.

Annual review of nutrition·2026
Same journal

From Food to Function: Cross-Kingdom Transfer and Regulatory Potential of Dietary microRNAs Highlighted by Breast Milk.

Annual review of nutrition·2026
Same journal

The Influence of Diet on Cancer Progression and Treatment.

Annual review of nutrition·2026
Same journal

The Potential Physiologic Mechanisms by Which Early-Life Nutrition May Influence Type 2 Diabetes Pathophysiology in Humans.

Annual review of nutrition·2026
Same journal

The Paradox and Future of GLP-1/GIP Combination Therapies: Efficacy and Mechanisms.

Annual review of nutrition·2026
See all related articles

Area of Science:

  • Skeletal physiology and pharmacology
  • Bone metabolism and disease
  • Fluoride toxicology

Background:

  • Sodium fluoride is a potent therapeutic agent affecting the skeleton.
  • Its skeletal effects present a duality of benefit and potential toxicity.
  • Current understanding of fluoride's mechanisms of action is incomplete.

Purpose of the Study:

  • To investigate the fundamental mechanisms behind sodium fluoride's skeletal effects.
  • To clarify the basis of both beneficial and detrimental actions of fluoride.
  • To inform potential modifications in therapeutic fluoride use.

Main Methods:

  • Review of existing clinical and preclinical data on sodium fluoride.
  • Analysis of pharmacological effects on bone tissue.

Related Experiment Videos

  • Evaluation of toxicological profiles associated with fluoride exposure.

    • Main Results:

    • Sodium fluoride demonstrates significant, yet dual, effects on skeletal tissues.
    • The precise mechanisms driving these beneficial and toxic effects require further elucidation.
    • Clinical applications are limited by the incomplete understanding of its action.

    Conclusions:

    • Sodium fluoride has profound skeletal effects, but its therapeutic use is complicated by toxicity.
    • A deeper understanding of fluoride's basic mechanisms is necessary for safer application.
    • Currently, sodium fluoride's clinical role is restricted to controlled research settings for osteoporosis and brittle bone diseases.